Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Revenue:
Total revenues	$ 0	$ 0	$ 0	$ 0
Operating Expenses:
Research and development	462,517	622,282	1,018,699	1,051,821
General and administrative	654,523	525,075	1,353,532	867,499
Total operating expenses	1,117,040	1,147,357	2,372,231	1,919,320
Loss from operations	(1,117,040)	(1,147,357)	(2,372,231)	(1,919,320)
Interest income	0	8,082	3,926	16,891
Net loss	(1,117,040)	(1,139,275)	(2,368,305)	(1,902,429)
Other comprehensive loss:
Foreign currency translation adjustment	(7,401)	(38,483)	(23,152)	(273,092)
Comprehensive loss	$ (1,124,441)	$ (1,177,758)	$ (2,391,457)	$ (2,175,521)
Net loss per share, basic and diluted	$ (0.01)	$ (0.01)	$ (0.01)	$ (0.01)
Weighted average number of common shares outstanding	208,021,967	205,003,261	207,929,675	155,957,363